The FDA's pausing its onsite inspections may have had negative consequences for drug quality, according to an analysis in Health Affairs. The agency said more inspections are coming.
New Study Finds FDA’s Inspection Pause May…
The FDA's pausing its onsite inspections may have had negative consequences for drug quality, according to an analysis in Health Affairs. The agency said more inspections are coming.